Related Image: Warming climate is changing life on global scale, says new study |
...Walter J. Lukiw, PhD, Associate Professor of Neuro...Center New Orleans, is the lead author of a paper ...on of a fragment of ribonucleic acid (RNA), once t...ng inflammation and the development of Alzheimer,s...146a-mediated inflammatory circuit in Alzheimer,s ...
...SANTA CRUZ, CA--An unusual microorganism discovere...k their understanding of how carbon and nitrogen c... by Jonathan Zehr, professor of ocean sciences at ...rized the new microbe by analyzing its genetic mat...to grow it in the laboratory. , Zehr said the ne...
...CHAPEL HILL Researchers from the University of No...ve been awarded almost $10 million to study the ma...y affect interactions between mothers and their in...dings will aid the development of new intervention... and prove valuable to others working in fields su...
Other Biology News:LSUHSC research identifies key contributor to Alzheimer's disease process 2Mysterious microbe may play important role in ocean ecology 2Mysterious microbe may play important role in ocean ecology 3UNC, Yale partner to study effects of cocaine use on mother-infant relationships 2(Date:11/24/2009)... The New York investment bank...ASX:NEU) has agreed an AU$6.7 mil convertible note...tor. The private placement was arranged by KTA Cap...isor. , New York (PRWEB) ...stment bank KTA Capital, LLC ("KTA Capital&qu...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCal...ill be presenting at the NASDAQ OMX conference on ...45 AM US/CST. Interested parties may listen via li... http://inve s tor.sig m a a ldrich.com/ ....s file. ,, About Sigma-Aldrich: Sigma-Ald...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4...ances Nfocus device development team. , , PALO AL... Nfocus Neuromedical Inc. announced today the ap...ert O,Holla to its leadership team in the role of ...,Holla brings an unmatched wealth of regulatory an... 18 of his last 30 years in the industry in the ro...
...idone role in treatment of patients with IPF - , ...t all-oral combination in HCV - , , - Strong data...in HCV - , , BRISBANE, Calif. , April 30 InterM...s from operations for the first quarter ended Marc...he first quarter of 2009 of $42.0 million, or $1.0...
...armaceuticals, Inc. (Nasdaq: IDIX ), a biopharma...lopment of drugs for the treatment of human viral ...ts for the first quarter ended March 31, 2009. At ...d marketable securities totaled $64.5 million. , ...st quarter of 2009, the company announced that it ...
Other Biology Technology:Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 3InterMune Reports First Quarter 2009 Financial Results and Business Highlights 4InterMune Reports First Quarter 2009 Financial Results and Business Highlights 5InterMune Reports First Quarter 2009 Financial Results and Business Highlights 6InterMune Reports First Quarter 2009 Financial Results and Business Highlights 7InterMune Reports First Quarter 2009 Financial Results and Business Highlights 8InterMune Reports First Quarter 2009 Financial Results and Business Highlights 9InterMune Reports First Quarter 2009 Financial Results and Business Highlights 10InterMune Reports First Quarter 2009 Financial Results and Business Highlights 11InterMune Reports First Quarter 2009 Financial Results and Business Highlights 12InterMune Reports First Quarter 2009 Financial Results and Business Highlights 13Idenix Pharmaceuticals Reports First Quarter Financial Results 2Idenix Pharmaceuticals Reports First Quarter Financial Results 3Idenix Pharmaceuticals Reports First Quarter Financial Results 4Idenix Pharmaceuticals Reports First Quarter Financial Results 5Idenix Pharmaceuticals Reports First Quarter Financial Results 6Goat Anti-KOR-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
T7Select1-1 OrientExpress cDNA Cloning System Random Primer from Novagen
Goat Anti-VAP-1 (S-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
... atoms at the 3, 3', 4, and 4' positions. It is in...ntification of Prostaglandin E2 (PGE2) by GC- or L...clooxygenase products of arachidonic acid and one ...s activity influences inflammation, fertility and ...
Biology Products: